| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |